Proteomics in discovery of hepatocellular carcinoma biomarkers

被引：0
|
作者：
Wu Cheng [1 ]
Li Song-Tao [2 ]
Liu Li-Jie [1 ]
Wang Zhan-Feng
Lu Jun-Hua [3 ]
Liu Bao-Hai [1 ]
Liao Ping [4 ]
Wang Wen-Jing [4 ]
Zhu Liang [1 ]
机构：
[1] Second Mil Med Univ, Dept Gastroenterol, Affiliated Hosp 2, Shanghai 200043, Peoples R China
[2] Second Mil Med Univ, Dept Surg, Eastern Hepatobiliary Surg Hosp, Shanghai 200043, Peoples R China
[3] China Sci & Technol Univ, Dept Stat & Finance, Beijing, Peoples R China
[4] Shanghai Municipal Ctr, Dept Publ Hlth & Mol Biol, Shanghai, Peoples R China
来源：
CHINESE JOURNAL OF CANCER RESEARCH | 2007年 / 19卷 / 03期
关键词：
proteomics; biomarker; hepatocellular carcinoma;
D O I：
10.1007/s11670-007-0159-5
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Objective: To discover new proteomic biomarkers of hepatocellular carcinoma. Methods: Surface enhanced laser desorption/ionization time-of-flight (SELDI-TOF) mass spectrometry was used to discover biomarkers for differentiating hepatocellular carcinoma and chronic liver disease. A population of 50 patients with hepatocellular carcinoma and 33 patients with chronic liver disease was studied. Results: Twelve proteomic biomarkers of hepatocellular carcinoma were detected in this study. Three proteomic biomarkers were highly expressed in hepatocellular carcinoma and nine proteomic biomarkers were highly expressed in chronic liver disease. The most valuable proteomic biomarker with m/z=11498 had no similar diagnostic value as alpha-fetoprotein. Conclusion: Some of the twelve proteomic biomarkers may become new biomarkers of hepatocellular carcinoma.
引用
收藏
页码：159 / 164
页数：6
相关论文
共 50 条
  • [41] Metabolic biomarkers of hepatocellular carcinoma
    Ressom, Habtom W.
    Xiao, Jun Feng
    Tuli, Leepika
    Varghese, Rency S.
    Zhou, Bin
    Tsai, Tsung-Heng
    Ranjbar, Mohammad R. Nezami
    Wang, Jinlian
    Cheema, Amrita K.
    Tadesse, Mahlet G.
    Goldman, Radoslav
    Shetty, Kirti
    CANCER RESEARCH, 2012, 72
  • [42] Comparative analysis of tissue proteomes for the discovery of biomarkers predicting high risk of hepatocellular carcinoma
    Hahm, Ki-baik
    Park, Yeong min
    Paik, Hyeon wook
    Yim, Dong jin
    Cho, Sung won
    GASTROENTEROLOGY, 2007, 132 (04) : A518 - A518
  • [43] Lysine Acetylome Study of Human Hepatocellular Carcinoma Tissues for Biomarkers and Therapeutic Targets Discovery
    Zhao, Qianwei
    Zhang, Zhendong
    Li, Jinxia
    Xu, Fang
    Zhang, Bingxia
    Liu, Mengduan
    Liu, Yixian
    Chen, Huiping
    Yang, Junxia
    Zhang, Jintao
    FRONTIERS IN GENETICS, 2020, 11
  • [44] Circulating biomarkers in hepatocellular carcinoma
    Karen L. Morris
    Jonathan D. Tugwood
    Leila Khoja
    Matthew Lancashire
    Robert Sloane
    Debbie Burt
    Patrick Shenjere
    Cong Zhou
    Clare Hodgson
    Toshihiko Ohtomo
    Atsuhiko Katoh
    Takahiro Ishiguro
    Juan W. Valle
    Caroline Dive
    Cancer Chemotherapy and Pharmacology, 2014, 74 : 323 - 332
  • [45] Biomarkers in hepatocellular carcinoma: an overview
    Juarez-Hernandez, Eva
    Motola-Kuba, Daniel
    Carlos Chavez-Tapia, Norberto
    Uribe, Misael
    Barbero Becerra, Varenka
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2017, 11 (06) : 549 - 558
  • [46] Erratum to: Biomarkers for hepatocellular carcinoma
    Goshi Shiota
    Norimasa Miura
    Clinical Journal of Gastroenterology, 2012, 5 (3) : 245 - 245
  • [47] Novel biomarkers in hepatocellular carcinoma
    De Stefano, Felice
    Chacon, Eduardo
    Turcios, Lilia
    Marti, Francesc
    Gedaly, Roberto
    DIGESTIVE AND LIVER DISEASE, 2018, 50 (11) : 1115 - 1123
  • [48] Prognostic Biomarkers for Hepatocellular Carcinoma
    Qi, Koh Rui
    Michelle, Pek Mi Xue
    Tan Min-Han
    PROCEEDINGS OF THE 4TH IRC CONFERENCE ON SCIENCE, ENGINEERING AND TECHNOLOGY, IRC-SET 2018, 2019, : 1 - 8
  • [49] Biomarkers for immunotherapy of hepatocellular carcinoma
    Greten, Tim F.
    Villanueva, Augusto
    Korangy, Firouzeh
    Ruf, Benjamin
    Yarchoan, Mark
    Ma, Lichun
    Ruppin, Eytan
    Wang, Xin W.
    NATURE REVIEWS CLINICAL ONCOLOGY, 2023, 20 (11) : 780 - 798
  • [50] Circulating biomarkers in hepatocellular carcinoma
    Morris, Karen L.
    Tugwood, Jonathan D.
    Khoja, Leila
    Lancashire, Matthew
    Sloane, Robert
    Burt, Debbie
    Shenjere, Patrick
    Zhou, Cong
    Hodgson, Clare
    Ohtomo, Toshihiko
    Katoh, Atsuhiko
    Ishiguro, Takahiro
    Valle, Juan W.
    Dive, Caroline
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, 74 (02) : 323 - 332
12345